254 related articles for article (PubMed ID: 26981734)
21. Risk of synchronous and metachronous second nonmelanoma skin cancer when referred for Mohs micrographic surgery.
Schinstine M; Goldman GD
J Am Acad Dermatol; 2001 Mar; 44(3):497-9. PubMed ID: 11209121
[TBL] [Abstract][Full Text] [Related]
22. Clinical spectrum of atypical fibroxanthoma and undifferentiated pleomorphic sarcoma in solid organ transplant recipients: a collective experience.
McCoppin HH; Christiansen D; Stasko T; Washington C; Martinez JC; Brown MD; Zwald FO
Dermatol Surg; 2012 Feb; 38(2):230-9. PubMed ID: 22129349
[TBL] [Abstract][Full Text] [Related]
23. Nonmelanoma skin cancers of the ear: correlation between subanatomic location and post-Mohs micrographic surgery defect size.
Duffy KL; McKenna JK; Hadley ML; Tristani-Firouzi P
Dermatol Surg; 2009 Jan; 35(1):30-3. PubMed ID: 19018813
[TBL] [Abstract][Full Text] [Related]
24. Merkel cell polyomavirus sequences are frequently detected in nonmelanoma skin cancer of immunosuppressed patients.
Kassem A; Technau K; Kurz AK; Pantulu D; Löning M; Kayser G; Stickeler E; Weyers W; Diaz C; Werner M; Nashan D; Zur Hausen A
Int J Cancer; 2009 Jul; 125(2):356-61. PubMed ID: 19384948
[TBL] [Abstract][Full Text] [Related]
25. Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin.
Harwood CA; Surentheran T; Sasieni P; Proby CM; Bordea C; Leigh IM; Wojnarowska F; Breuer J; McGregor JM
Br J Dermatol; 2004 May; 150(5):949-57. PubMed ID: 15149508
[TBL] [Abstract][Full Text] [Related]
26. Mohs micrographic surgery and surgical excision for nonmelanoma skin cancer treatment in the Medicare population.
Viola KV; Jhaveri MB; Soulos PR; Turner RB; Tolpinrud WL; Doshi D; Gross CP
Arch Dermatol; 2012 Apr; 148(4):473-7. PubMed ID: 22508870
[TBL] [Abstract][Full Text] [Related]
27. Use of Digitally Stained Multimodal Confocal Mosaic Images to Screen for Nonmelanoma Skin Cancer.
Mu EW; Lewin JM; Stevenson ML; Meehan SA; Carucci JA; Gareau DS
JAMA Dermatol; 2016 Dec; 152(12):1335-1341. PubMed ID: 27603676
[TBL] [Abstract][Full Text] [Related]
28. Spectrum of Nonkeratinocyte Skin Cancer Risk Among Solid Organ Transplant Recipients in the US.
Sargen MR; Cahoon EK; Yu KJ; Madeleine MM; Zeng Y; Rees JR; Lynch CF; Engels EA
JAMA Dermatol; 2022 Apr; 158(4):414-425. PubMed ID: 35262623
[TBL] [Abstract][Full Text] [Related]
29. Epithelial skin cancers after kidney transplantation: a retrospective single-centre study of 376 recipients.
Kaufmann RA; Oberholzer PA; Cazzaniga S; Hunger RE
Eur J Dermatol; 2016 Jun; 26(3):265-70. PubMed ID: 26985913
[TBL] [Abstract][Full Text] [Related]
30. Capecitabine to reduce nonmelanoma skin carcinoma burden in solid organ transplant recipients.
Endrizzi B; Ahmed RL; Ray T; Dudek A; Lee P
Dermatol Surg; 2013 Apr; 39(4):634-45. PubMed ID: 23379978
[TBL] [Abstract][Full Text] [Related]
31. The Skin Cancer Index: quality-of-life outcomes of treatments for nonmelanoma skin cancer.
Sanchez N; Griggs J; Nanda S; Fayne R; Castillo D; De Bedout V; Meirson D; Nichols A
J Dermatolog Treat; 2020 Aug; 31(5):491-493. PubMed ID: 31566077
[No Abstract] [Full Text] [Related]
32. Nonmelanoma skin cancer in solid organ transplant recipients: update on epidemiology, risk factors, and management.
Tessari G; Girolomoni G
Dermatol Surg; 2012 Oct; 38(10):1622-30. PubMed ID: 22805312
[TBL] [Abstract][Full Text] [Related]
33. Variation in Nonmelanoma Skin Cancer Incidence by Treatment Modality Among Patients Receiving Multiple Kidney Transplants.
Sexton DJ; O'Kelly P; O'Leary E; Murray S; Deady S; Daly F; Egan J; Houlihan DD; McCormick PA; Morris PG; Ni Raghallaigh S; Moloney FJ; O'Neill JP; Conlon PJ
JAMA Dermatol; 2019 May; 155(5):594-598. PubMed ID: 30725084
[TBL] [Abstract][Full Text] [Related]
34. Correlation of Inflammation in Frozen Sections With Site of Nonmelanoma Skin Cancer.
Alam M; Khan M; Veledar E; Pongprutthipan M; Flores A; Dubina M; Nodzenski M; Yoo SS
JAMA Dermatol; 2016 Feb; 152(2):173-6. PubMed ID: 26579703
[TBL] [Abstract][Full Text] [Related]
35. Mammalian target of rapamycin inhibitors for prolonged secondary prevention of nonmelanoma skin cancer in solid organ transplant recipients.
Gluck M; Hodak E; Davidovici B
Dermatol Ther; 2022 Aug; 35(8):e15649. PubMed ID: 35716099
[TBL] [Abstract][Full Text] [Related]
36. Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia.
Carroll RP; Ramsay HM; Fryer AA; Hawley CM; Nicol DL; Harden PN
Am J Kidney Dis; 2003 Mar; 41(3):676-83. PubMed ID: 12612993
[TBL] [Abstract][Full Text] [Related]
37. Mohs micrographic surgery: 10 year experience in Puerto Rico.
Sosa-Seda IM; González R; Mercado R; Ruiz H; Figueroa LD
P R Health Sci J; 2014 Mar; 33(1):22-6. PubMed ID: 24665605
[TBL] [Abstract][Full Text] [Related]
38. Risk of Rare Cancers Among Solid Organ Transplant Recipients.
D'Arcy ME; Castenson D; Lynch CF; Kahn AR; Morton LM; Shiels MS; Pfeiffer RM; Engels EA
J Natl Cancer Inst; 2021 Feb; 113(2):199-207. PubMed ID: 32462187
[TBL] [Abstract][Full Text] [Related]
39. The role of new immunosuppressive drugs in nonmelanoma skin cancer in renal transplant recipients.
Bernat-García J; Morales Suárez-Varela M; Vilata-Corell JJ; Marquina-Vila A; Pallardo L; Crespo J
Actas Dermosifiliogr; 2014 Dec; 105(10):940-6. PubMed ID: 25062648
[TBL] [Abstract][Full Text] [Related]
40. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]